Richard Morat T
@goiter04.bsky.social
Internal Medicine-Endocrinologist MD MScHealth-Professor of Thyrod Ultrasound 2000-2018- 🇪🇸BCN-Toronto 🇨🇦
Reposted by Richard Morat T
Subclinical Diabetic Cardiomyopathy: Detectable but Not Yet Actionable www.ahajournals.org/doi/10.1161/...
Subclinical Diabetic Cardiomyopathy: Detectable but Not Yet Actionable | Journal of the American Heart Association
www.ahajournals.org
October 3, 2026 at 3:25 AM
Subclinical Diabetic Cardiomyopathy: Detectable but Not Yet Actionable www.ahajournals.org/doi/10.1161/...
Subclinical Diabetic Cardiomyopathy: Detectable but Not Yet Actionable www.ahajournals.org/doi/10.1161/...
Subclinical Diabetic Cardiomyopathy: Detectable but Not Yet Actionable | Journal of the American Heart Association
www.ahajournals.org
October 3, 2026 at 3:25 AM
Subclinical Diabetic Cardiomyopathy: Detectable but Not Yet Actionable www.ahajournals.org/doi/10.1161/...
Reposted by Richard Morat T
Reframing menopause and menopause hormone therapy as opportunities for healthy aging www.science.org/doi/10.1126/...
Reframing menopause and menopause hormone therapy as opportunities for healthy aging
Menopause is an important biological transition with up to 72 symptoms that shapes aging trajectories across organs and encompasses ~40% of the female lifespan. Although menopause awareness is increas...
www.science.org
October 2, 2026 at 8:12 PM
Reframing menopause and menopause hormone therapy as opportunities for healthy aging www.science.org/doi/10.1126/...
Reposted by Richard Morat T
Artificial intelligence in clinical neurophysiology: IFCN handbook chapter www.sciencedirect.com/science/arti...
Artificial intelligence in clinical neurophysiology: IFCN handbook chapter
Artificial intelligence (AI) has the potential to transform clinical neurophysiology by enabling the automated analysis of complex physiological signa…
www.sciencedirect.com
October 2, 2026 at 8:10 PM
Artificial intelligence in clinical neurophysiology: IFCN handbook chapter www.sciencedirect.com/science/arti...
Reposted by Richard Morat T
The list of reported benefits of the GLP-1 drug family that are weight-loss independent continues to grow. My tally with citations
October 2, 2026 at 7:43 PM
The list of reported benefits of the GLP-1 drug family that are weight-loss independent continues to grow. My tally with citations
Reframing menopause and menopause hormone therapy as opportunities for healthy aging www.science.org/doi/10.1126/...
Reframing menopause and menopause hormone therapy as opportunities for healthy aging
Menopause is an important biological transition with up to 72 symptoms that shapes aging trajectories across organs and encompasses ~40% of the female lifespan. Although menopause awareness is increas...
www.science.org
October 2, 2026 at 8:12 PM
Reframing menopause and menopause hormone therapy as opportunities for healthy aging www.science.org/doi/10.1126/...
Artificial intelligence in clinical neurophysiology: IFCN handbook chapter www.sciencedirect.com/science/arti...
Artificial intelligence in clinical neurophysiology: IFCN handbook chapter
Artificial intelligence (AI) has the potential to transform clinical neurophysiology by enabling the automated analysis of complex physiological signa…
www.sciencedirect.com
October 2, 2026 at 8:10 PM
Artificial intelligence in clinical neurophysiology: IFCN handbook chapter www.sciencedirect.com/science/arti...
Reposted by Richard Morat T
Therapeutic strategies for Takotsubo syndrome: from acute management to long-term recovery and recurrence prevention. ahajrnls.org/46XK2hP
Therapeutic Strategies for Takotsubo Syndrome: A Comprehensive Clinical Review | Journal of the American Heart Association
ahajrnls.org
October 2, 2026 at 8:08 PM
Therapeutic strategies for Takotsubo syndrome: from acute management to long-term recovery and recurrence prevention. ahajrnls.org/46XK2hP
Reposted by Richard Morat T
Reposted by Richard Morat T
Original Article: Survodutide Once Weekly in Adults with Obesity and Type 2 Diabetes (phase 3 SYNCHRONIZE-2 trial) nej.md/4yrHEMu
Survodutide Once Weekly in Adults with Obesity and Type 2 Diabetes | NEJM
For persons living with both type 2 diabetes and obesity, weight management may be the most effective therapy for type 2 diabetes. Glucagon-like peptide-1 (GLP-1) receptor agonists have potent weig...
nej.md
October 2, 2026 at 8:05 PM
Original Article: Survodutide Once Weekly in Adults with Obesity and Type 2 Diabetes (phase 3 SYNCHRONIZE-2 trial) nej.md/4yrHEMu
Reposted by Richard Morat T
Management of Type 2 Diabetes, 2026. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
diabetesjournals.org/care/article...
diabetesjournals.org/care/article...
Management of Type 2 Diabetes, 2026. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
The American Diabetes Association and the European Association for the Study of Diabetes convened a panel to update the consensus statement on the manageme
diabetesjournals.org
October 2, 2026 at 7:55 PM
Management of Type 2 Diabetes, 2026. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
diabetesjournals.org/care/article...
diabetesjournals.org/care/article...
Therapeutic strategies for Takotsubo syndrome: from acute management to long-term recovery and recurrence prevention. ahajrnls.org/46XK2hP
Therapeutic Strategies for Takotsubo Syndrome: A Comprehensive Clinical Review | Journal of the American Heart Association
ahajrnls.org
October 2, 2026 at 8:08 PM
Therapeutic strategies for Takotsubo syndrome: from acute management to long-term recovery and recurrence prevention. ahajrnls.org/46XK2hP
Original Article: Survodutide Once Weekly in Adults with Obesity and Type 2 Diabetes (phase 3 SYNCHRONIZE-2 trial) nej.md/4yrHEMu
Survodutide Once Weekly in Adults with Obesity and Type 2 Diabetes | NEJM
For persons living with both type 2 diabetes and obesity, weight management may be the most effective therapy for type 2 diabetes. Glucagon-like peptide-1 (GLP-1) receptor agonists have potent weig...
nej.md
October 2, 2026 at 8:05 PM
Original Article: Survodutide Once Weekly in Adults with Obesity and Type 2 Diabetes (phase 3 SYNCHRONIZE-2 trial) nej.md/4yrHEMu
Management of Type 2 Diabetes, 2026. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
diabetesjournals.org/care/article...
diabetesjournals.org/care/article...
Management of Type 2 Diabetes, 2026. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
The American Diabetes Association and the European Association for the Study of Diabetes convened a panel to update the consensus statement on the manageme
diabetesjournals.org
October 2, 2026 at 7:55 PM
Management of Type 2 Diabetes, 2026. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
diabetesjournals.org/care/article...
diabetesjournals.org/care/article...
jnccn.org
January 24, 2025 at 3:59 AM
jnccn.org
January 24, 2025 at 3:59 AM
jnccn.org
January 24, 2025 at 3:56 AM
Reposted by Richard Morat T
Cool new trial by @millionmarker.bsky.social on reducing EDC exposure:
trialsjournal.biomedcentral.com/articles/10....
trialsjournal.biomedcentral.com/articles/10....
Reducing Exposures to Endocrine Disruptors (REED) study, a personalized at-home intervention program to reduce exposure to endocrine disrupting chemicals among a child-bearing age cohort: study protoc...
Background Exposures to endocrine disrupting chemicals (EDCs) have been linked to chronic diseases including breast cancer, metabolic syndrome, diabetes, and infertility. Exposure during pregnancy may...
trialsjournal.biomedcentral.com
November 26, 2024 at 3:27 PM
Cool new trial by @millionmarker.bsky.social on reducing EDC exposure:
trialsjournal.biomedcentral.com/articles/10....
trialsjournal.biomedcentral.com/articles/10....
Reposted by Richard Morat T
#RobertFKennedyJr is working with #AaronSiri, a lawyer who specializes in suing vaccine manufacturers and has filed multiple petitions to get #vaccine approvals revoked.
December 14, 2024 at 1:37 PM
#RobertFKennedyJr is working with #AaronSiri, a lawyer who specializes in suing vaccine manufacturers and has filed multiple petitions to get #vaccine approvals revoked.
